Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01695525 · ClinicalTrials.gov registry record · Early Phase 1
Influence of Yoga in Patients With Neurocardiogenic Syncope
A Early Phase 1 study, sponsored by Dhanunjaya Lakkireddy, MD, FACC.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT01695525 is a Early Phase 1 study that has completed, run by Dhanunjaya Lakkireddy, MD, FACC. The registered enrollment target is 8 participants.
The verdict
NCT01695525, a Early Phase 1 study, has completed, sponsored by Dhanunjaya Lakkireddy, MD, FACC.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
Syncope is a common problem that many clinicians may encounter in various outpatient settings. Neurocardiogenic syncope (NCS) is a benign condition characterized by a self limited episode of systemic hypotension. Patients are usually managed with education on syncope, anxiety management, and coping skills. It has been established that practice of Yoga could relieve stress and anxiety. In a different study, they also found that Yoga positively influences cardiovascular function by decreasing the heart rate and blood pressure. The main objective of Yoga is to achieve control over the autonomic nervous system and able to control functions like heart rate, blood pressure and respiratory rate. Based on the findings that Yoga relieves stress and reduces heart rate, the investigators propose to study if Yoga can decrease the frequency of NCS and also reduce the symptoms associated with these episodes.
Interventions
- OTHER Yoga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01695525
The ClinicalTrials.gov registry entry for NCT01695525 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dhanunjaya Lakkireddy, MD, FACC, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Yoga is the first listed.
NCT01695525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01695525 about?
NCT01695525 is a clinical study titled "Influence of Yoga in Patients With Neurocardiogenic Syncope". Syncope is a common problem that many clinicians may encounter in various outpatient settings. Neurocardiogenic syncope (NCS) is a benign condition characterized by a self limited episode of systemic hypotension. Patients are usually managed with education on syncope, anxiety management, and coping ...
What is the current status of trial NCT01695525?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2012-06. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01695525?
The interventions under investigation include: Yoga (OTHER).
Who is sponsoring clinical trial NCT01695525?
This trial is sponsored by Dhanunjaya Lakkireddy, MD, FACC, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.